Reine Allan
Insider CIK 1714023 · PIRS See Remarks · FHTX Chief Financial Officer · PRME Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRME Prime Medicine, Inc. | A Award deriv | 2026-02-26 | 2026-02-27 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 850,000 | — | $0 | 850,000 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 850,000 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2025-05-21 | 2025-05-22 | 125,000 | $1.18 | $147.5K | 125,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-05-19 | 2025-05-19 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-05-08 | 2025-05-12 | 75,000 | — | $0 | 850,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 275,000 | — | $0 | 275,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-12-05 | 2024-12-09 | 75,000 | — | $0 | 775,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-05-17 | 2024-05-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-01-17 | 2024-01-19 | 600,000 | — | $0 | 600,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2023-01-26 | 2023-01-30 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2022-01-26 | 2022-01-28 | 135,000 | — | $0 | 135,000 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | M Exercise deriv | 2021-08-09 | 2021-08-11 | 26,892 | — | $0 | 257,512 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | M Exercise | 2021-08-09 | 2021-08-11 | 26,892 | $3.72 | $100.0K | 53,784 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2021-01-28 | 2021-02-01 | 120,000 | — | $0 | 120,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-02-26 | 2019-02-28 | 162,500 | — | $0 | 162,500 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-02-20 | 2018-02-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-02-20 | 2018-02-26 | 53,833 | — | $0 | 53,833 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2017-08-17 | 2017-08-17 | 20,000 | $4.89 | $97.8K | 65,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2017-08-16 | 2017-08-17 | 45,000 | $4.79 | $215.6K | 45,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2017-08-09 | 2017-08-11 | 450,000 | — | $0 | 450,000 | SEC↗ |